Common decongestants may soon be pulled from shelves. The Food and Drug Administration (FDA) announced Wednesday its proposal ...
Health experts have argued that UK customers are being hoodwinked by the drug firms behind the 'useless' medicines - which include Sudafed, Lemsip and Beechams.
At the first sign of a runny nose many people dash out to buy a cold and flu remedy - but soon that might become harder to do ...
ALK has a market cap of $36.8bn. Neffy became the first and only approved nasal spray medicine to treat severe allergic ...
The U.S. Food and Drug Administration is taking the first step to remove an ingredient in non-prescription cold medicines ...
ALK and ARS Pharmaceuticals sign a deal giving ALK global rights to Neffy nasal spray outside key regions, targeting peak sales of around $400 million in anaphylaxis treatment.
Although ARS Pharmaceuticals’ approval for its epinephrine nasal spray came later than expected, the company ultimately received a thumbs up from the FDA in August and is now moving fast to expand ...
Phenylephrine is included in many cold and flu products, but a scientific panel last year found that it doesn't really do its ...
Oral phenylephrine is used in over-the-counter products like Sudafed and Dayquil to help temporarily relieve the common ...
Phenylephrine is both the most common decongestant on pharmacy shelves, and arguably the worst at its job. Last year, the FDA ...
On Thursday, the FDA proposed removing oral phenylephrine from the list of approved active ingredients for over-the-counter ...
On September 20, 2024, the U.S. Food and Drug Administration (FDA) approved the first influenza (flu) vaccine for at‑home use. The vaccine, ...